Brazilian Breast Sculpting: A Standardized Approach to Mastopexy Without Implants

The authors evaluated the feasibility, safety, and patient-reported outcomes of a standardized autologous protocol ("Brazilian Breast Sculpting") that integrates liposuction, Liacyr flap creation, intramuscular and subcutaneous fat grafting, a muscular sling, and an internal bra. In this prospective case series, 38 patients (mean age 44 years; BMI ≤28) underwent the 6-step protocol between January 2023 and November 2024 and completed at least 12 months of follow-up. Patient-reported outcomes were assessed at 12 months using the Brazilian Portuguese version of the BREAST-Q reduction/mastopexy module. All patients completed the standardized protocol. Postoperative morbidity was low; wound dehiscence occurred in 5 patients (13.2%) and suture extrusion in 7 (18.4%), with all cases managed conservatively. At 12 months, mean BREAST-Q scores (0-100) suggested high satisfaction, particularly for satisfaction with breasts and physical well-being (chest). These preliminary findings suggest that Brazilian Breast Sculpting is a feasible autologous approach to mastopexy without implants with favorable patient-reported outcomes and an acceptable safety profile. Level of Evidence: 4 (Therapeutic).